These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhibition of endotoxin response by synthetic TLR4 antagonists. Hawkins LD; Christ WJ; Rossignol DP Curr Top Med Chem; 2004; 4(11):1147-71. PubMed ID: 15279606 [TBL] [Abstract][Full Text] [Related]
11. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122 [TBL] [Abstract][Full Text] [Related]
12. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235 [TBL] [Abstract][Full Text] [Related]
13. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Opal SM Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016 [TBL] [Abstract][Full Text] [Related]
14. [The new antiendotoxin strategies]. Wang DN; Zhang WJ; Wu XF Sheng Wu Gong Cheng Xue Bao; 2001 May; 17(3):241-5. PubMed ID: 11517592 [TBL] [Abstract][Full Text] [Related]
15. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants. Rubin RM; Noland J; Rosenbaum JT Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103 [TBL] [Abstract][Full Text] [Related]
16. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902 [TBL] [Abstract][Full Text] [Related]
17. Initial responses to endotoxins and Gram-negative bacteria. Heumann D; Roger T Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807 [TBL] [Abstract][Full Text] [Related]
18. Current prospects for the treatment of clinical sepsis. Suffredini AF Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188 [TBL] [Abstract][Full Text] [Related]
19. [The application of molecular biology to anti-endotoxin therapies]. Someya T; Sasaki K; Hirata K Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):523-6. PubMed ID: 12884777 [TBL] [Abstract][Full Text] [Related]
20. Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response. Wheeler DS; Zingarelli B; Wheeler WJ; Wong HR Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):96-112. PubMed ID: 19519586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]